BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Bufexamac

A benzeneacetamide with anti-inflammatory, analgesic, and antipyretic action. It is administered topically, orally, or rectally.

137+ PubMed studies analyzed · 9 RCTs · Evidence Score: 47.2

Research Domains

Bufexamac has been studied across 7 research domains including 🔬 Inflammation, ✨ Skin & Hair, 🦴 Bone & Joint, 💊 Pain, 🔥 Metabolic. The primary research focus is 🔬 Inflammation with 56% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Bufexamac, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

casin
6 shared targets
Lumefantrine
8 shared targets
Azathioprine
10 shared targets
Flumethasone
6 shared targets
Teniposide
5 shared targets
deguelin
6 shared targets
Melphalan
11 shared targets
Phenelzine
8 shared targets
darapladib
7 shared targets
Fluvastatin
4 shared targets
Loading evidence profile...

This evidence profile for Bufexamac is generated deterministically from 137 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.